SBRT for Medically Inoperable Early Stage Lung Cancer a Key Topic for Elekta ...
/PRNewswire/ -- During the 14th World Conference on Lung Cancer, leading users of Elekta Stereotactic Body Radiation Therapy (SBRT) technology presented their findings on the use of SBRT to treat early stage, non-small cell lung cancer (NSCLC). The most common form of lung cancer, NSCLC arises from a number of causes, including active smoking, passive smoking (secondhand smoke), and exposure to other carcinogens.In an oral presentation, Dr. Andrew J. Hope, Radiation Oncologist, Princess Margaret Hospital (Toronto, Canada) discussed the experience of a multinational consortium of Elekta collaborators that has treated operable, early stage lung cancer. Titled, Outcomes of operable patients with non-small cell lung carcinoma (NSCLC) treated with image guided stereotactic body radiation therapy (IG-SBRT), the consortium found that the 505 tumors in the 483 operable patients declining a thoracotomy and subsequently treated with IG-SBRT had overall survival and cancer-specific outcomes similar to reported surgical series. With the condition that additional follow-up would be required, the data support continued investigation of IG-SBRT, suggesting that IG-SBRT is potentially an equivalent alternative to surgery in operable patients with early stage lung cancer.
According to Dr. Hope, this finding supports ongoing clinical trials that are comparing non-invasive radiation treatments, such as IG-SBRT, with surgery. "It may be that someday, patients could choose between a thoracotomy or a completely non-invasive approach to cure early stage lung cancer*."
Dr. Hope is a member of the Elekta Lung Research Group (ELRG), an international collaboration of physicians and physicists that is evaluating clinical outcomes in early stage NSCLC patients. To date, they have accumulated data on more than 500 such patients and identified medical and technical factors that affect tumor control and toxicity. Their collective experience is among the largest multinational series of patients treated with IG-SBRT to date.
The ELRG includes participants from William Beaumont Hospital in Royal Oak, Michigan; Princess Margaret Hospital; Thomas Jefferson University in Philadelphia, Pennsylvania; Julius-Maximilians University of Wurzburg in Wurzburg, Germany; and The Netherlands Cancer Institute-Antoni van Leeuwenhoek hospital in Amsterdam, The Netherlands.
Advanced Elekta SBRT technology used today includes Elekta Axesse™ and Elekta Synergy® S treatment systems, as well as Symmetry™ and Intuity™ software**. Symmetry is a breakthrough technology that enables highly accurate, yet completely non-invasive lung tumor treatments without requiring additional intra-fraction radiation imaging. Intuity ensures that the positions of both the tumor and nearby healthy critical structures are accounted for. These two innovations contribute to a more patient-friendly and safe treatment.
Non Small Cell Lung Cancer Surgery - News
Titled, Outcomes of operable patients with non-small cell lung carcinoma (NSCLC) treated with image guided stereotactic body radiation therapy (IG-SBRT), the consortium found that the 505 tumors in the 483 operable patients declining a thoracotomy and
miRview® mets and miRview® mets² accurately identify the primary tumor site in metastatic cancer and CUP. miRview® squamous accurately identifies the squamous subtype of non-small cell lung cancer, which carries an increased risk of severe or fatal
[Medline] Izbicki JR, Passlick B, Pantel K, Pichlmeier U, Hosch SB, Karg O, et al. Effectiveness of radical systematic mediastinal lymphadenectomy in patients with resectable non–small cell lung cancer: results of a prospective randomized trial.
Pharmafocus presents selected highlights from the American Society of Clinical Oncology's annual meeting in Chicago, beginning with non-small cell lung cancer (NSCLC). Pfizer's targeted NSCLC treatment crizotinib was one of the highlights of ASCO last
July 14, 2011 (Amsterdam, the Netherlands) — New data support the use of endoscopic approaches in the initial staging process for nonsmall-cell lung cancer (NSCLC), using surgery as a backup. Two presentations here at the 14th World Conference on Lung
The small cell lung cancer surgery | treatments for lung cancer
&Nbsp; Non-small cell lung cancer accounts for about 80-85% of the total number of lung cancer, including squamous cell carcinoma, gland cancer, large cell carcinoma.Relative to the small cell lung cancer for, the small cell lung cancer grew more slowly, and the transfer also slower, even so, the vast majority of small cell lung cancer at time of diagnosis, treatment, present situation of the later has not ideal.Now the non-small cell 3. Sleeve shape lobectomy and wedge resection: this kind of sleeve lobectomy procedures used in right lung takes in more than the middle, such as lung cancer, the mass located in leaves, and the leaves of bronchial involving the bronchial openings, feasible sleeve shape lobectomy;If not involving the leaf bronchial openings, feasible wedge sleeve lobectomy shape.
Management of N2/IIIA Non-Small-cell Lung Cancer, An Issue of Thoracic Surgery Clinics (The Clinics: Surgery): 
Management of Stage I Non-Small Cell Lung Cancer, An Issue of Thoracic Surgery Clinics (The Clinics: Surgery): 
Recently had thoracic surgery, for non small cell lung cancer what are my chances of the lung cancer returning plastic surgery
: Non Small Cell Lung Cancer Surgery - Bookshelf
General Thoracic Surgery
Preoperative chemoradiotherapy and surgery for selected non-small cell lung cancer IIIB subgroups: long-term results. Ann Thorac Surg 1999;68:1144. ...Essential practice of surgery, basic science and clinical evidence
A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer. ...Advances in radiation oncology in lung cancer
... as a neo-adjuvant treatment for stage III non-small cell lung cancer. .... with surgery alone in resectable stage IIIA non- small cell lung cancer. ...Surgery, basic science and clinical evidence
Surgical treatment of stage IV non-small cell lung cancer, in Diagnosis and ... A randomized trial to assess the efficacy of surgery in addition to ...Lung cancer
Topics covered in this volume include the clinical examination of patients with suspected lung cancer, thoracic imaging techniques for non-small cell and small ...Everyday Note Directory
Non-Small Cell Lung Cancer Treatment (PDQ®) - National Cancer ...
Expert-reviewed information summary about the treatment of non-small cell lung cancer.
Lung Cancer - Wikipedia
User-edited article about lung cancer, the disease of uncontrolled cell growth in tissues of the lung. Includes its types, causes, staging, treatment, and prognosis.
Non-Small Cell Lung Cancer - Overview of Non-Small Cell Lung ...
Non-small cell lung cancer is the most common form of lung cancers. What types of lung cancers are classified as non-small cell lung cancer, and what ...
Non-Small Cell Treatment Options at Fox Chase Cancer Center
Primary treatment for non-small cell lung cancer depends on the stage of the disease. ... Not all patients with lung cancer are candidates for surgery. ...
Lung Cancer Home Page - National Cancer Institute
Information about lung cancer treatment, prevention, causes, screening, clinical trials, research, statistics and other topics from the National Cancer Institute.